The clinical relevance of C1-INH for complement evasion of the tumor is underlined by the fact that PDAC patients with high C1-INH expression had a 5-year survival of 15% compared to 56% when the C1-INH level is low [85]. Here, SERPING1 is linked to neoplasm.